Rewind Pause Forward

Portfolio

Sarissa Biomedical

Sarissa Biomedical is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity/disorders.

Click here to view our full portfolio

0

Mercia Fund Management is an active investor in key technology companies located in Central England.

Funds open for investment

Mercia Growth EIS Fund - £10m opportunity offering a series of tax benefits including up to 30% income tax relief, CGT deferral and inheritance tax exemption.

Last chance to receive an Early Bird incentive!

Click here for further information.

Investment provision
Portfolio
Business support
Sources of assistance

Quick Contact